Mega mergers can't cure the pharmaceutical industry
BusinessWeek Online 7/26/2009
by Preston Henske and Tim van Biesen
Big pharmaceutical companies may gain more from collaborating on research and development than from mega mergers.
Private equity must skill up for the upturn
Financial Times 7/19/2009
by Graham Elton and Hugh MacArthur
Private equity firms that use the downturn to identify and build relationships with sector-leading companies should be well positioned to pull away from their rivals coming out of the downturn.
Taming costly complexity in service businesses
Strategy & Leadership 7/1/2009
by Mark Gottfredson and Andrew Schwedel
Most managers recognize that complexity hurts their businesses, but it is an especially pernicious problem for service companies. All service businesses aspire to be innovation leaders, provide great customer experiences, and tailor products to the needs of their customers. Only those that can accomplish these goals while taming complexity will achieve profitable growth.
The real reason big pharma mergers are wise
Forbes.com 6/26/2009
by Charles Farkas and Tim van Biesen
The giants of the pharmaceutical industry may have found their salvation in the wave of consolidation that's changing the face of the industry. With these deals companies have built a robust business model for competing in the new global marketplace. Speed to market really matters; and in that kind of game, scale can be a huge advantage.
Making bank mergers work in Taiwan
Far Eastern Economic Review 6/23/2009
by Nick Palmer and Keng Koay
Challenging even in the best of times, Taiwan's banking market harbors hidden perils with the economy in tumult. Acquirers need to be prepared for these challenges from the very start and formulate plans to quickly mitigate the risk. Those who are alert to the pitfalls as well as the potential opportunities will emerge as winners.
|
|
|
Follow us on Twitter